Search for Clinical Trial Results
Childhood Hepatocellular Carcinoma - 9 Studies Found
| Status | Study |
| Recruiting |
Study Name: Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery Condition:
|
| Active, not recruiting |
Study Name: Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery Condition:
|
| Completed |
Study Name: Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer Condition:
|
| Withdrawn |
Study Name: Biomarkers in Stored Tumor Samples From Younger Patients With Liver Cancer Condition: Liver Cancer Date: 2009-05-09 Interventions:
|
| Withdrawn |
Study Name: Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by Surgery Condition: Liver Cancer Date: 2007-05-08 Interventions:
|
| Withdrawn |
Study Name: Combination Chemotherapy and Thalidomide in Treating Younger Patients Undergoing Surgery For Newly Diagnosed Liver Cancer Condition: Liver Cancer Date: 2006-01-12 Interventions:
|
| Completed |
Study Name: Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor Condition: Cancer Date: 2005-09-08 Interventions: Biological: therapeutic allogeneic lymphocytes The total CD3+ cell dose target is 1.8 x 108 CD3+ cells/k |
| Completed |
Study Name: Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases Condition:
Interventions: |
| Completed |
Study Name: Chemotherapy in Treating Children With Liver Cancer Condition: Liver Cancer Date: 1999-11-01 Interventions:
|